Ken Herrmann

机构：German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, Düsseldorf University Hospital, National Center for Tumor Diseases, Essen University Hospital, West German Heart and Vascular Center Essen, Deutsches Konsortium für Translationale Krebsforschung, Heinrich Heine University Düsseldorf, University of Duisburg-Essen · ORCID：0000-0002-9662-7259

发表论文 966 篇 · 总被引 35987 次 · h-index 97

代表论文

• The molecular blueprint of targeted radionuclide therapy (2025 · Nature Reviews Clinical Oncology · 被引 44)
• PSMA PET/CT Reporting: Real-Life Inconsistencies, Heterogeneity, and Underutilization of Scoring Systems and Interpretation Frameworks (2025 · Radiology · 被引 8)
• Thyroid Hormone Withdrawal Yields Higher 131 I Absorbed Dose to Metastases Than rhTSH Stimulation in Differentiated Thyroid Cancer: Evidence from a Large 124 I PET/CT Dosimetry Cohort (2025 · Journal of Nuclear Medicine · 被引 4)
• Navigating the Scoring Systems and Interpretation Frameworks of Prostate-specific Membrane Antigen PET (2025 · Radiology · 被引 3)
• New targets of PET imaging for renal cancer (2025 · Seminars in Nuclear Medicine · 被引 2)
• The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate Cancer (2025 · Journal of Nuclear Medicine · 被引 2)